Department of Cardiology, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.
Netherlands Heart Institute, Moreelsepark 1, Utrecht, The Netherlands.
Basic Res Cardiol. 2018 Nov 12;114(1):1. doi: 10.1007/s00395-018-0709-7.
Monocytes are involved in adverse left ventricular (LV) remodelling following myocardial infarction (MI). To provide therapeutic opportunities we aimed to identify gene transcripts in monocytes that relate to post-MI healing and evaluated intervention with the observed gene activity in a rat MI model. In 51 MI patients treated by primary percutaneous coronary intervention (PCI), the change in LV end-diastolic volume index (EDVi) from baseline to 4-month follow-up was assessed using cardiovascular magnetic resonance imaging (CMR). Circulating monocytes were collected at day 5 (Arterioscler Thromb Vasc Biol 35:1066-1070, 2015; Cell Stem Cell 16:477-487, 2015; Curr Med Chem 13:1877-1893, 2006) after primary PCI for transcriptome analysis. Transcriptional profiling and pathway analysis revealed that patients with a decreased LV EDVi showed an induction of type I interferon (IFN) signalling (type I IFN pathway: P value < 0.001; false discovery rate < 0.001). We subsequently administered 15,000 Units of IFN-α subcutaneously in a rat MI model for three consecutive days following MI. Cardiac function was measured using echocardiography and infarct size/cardiac inflammation using (immuno)-histochemical analysis. We found that IFN-α application deteriorated ventricular dilatation and increased infarct size at day 28 post-MI. Moreover, IFN-α changed the peripheral monocyte subset distribution towards the pro-inflammatory monocyte subset whereas in the myocardium, the presence of the alternative macrophage subset was increased at day 3 post-MI. Our findings suggest that induction of type I IFN signalling in human monocytes coincides with adverse LV remodelling. In rats, however, IFN-α administration deteriorated post-MI healing. These findings underscore important but also contradictory roles for the type I IFN response during cardiac healing following MI.
单核细胞参与心肌梗死后左心室(LV)的不良重构。为了提供治疗机会,我们旨在鉴定与梗死后愈合相关的单核细胞中的基因转录本,并在大鼠心肌梗死模型中评估观察到的基因活性的干预效果。在接受经皮冠状动脉介入治疗(PCI)的 51 例 MI 患者中,使用心血管磁共振成像(CMR)评估基线至 4 个月随访时 LV 舒张末期容积指数(EDVi)的变化。在初次 PCI 后第 5 天(Arterioscler Thromb Vasc Biol 35:1066-1070, 2015; Cell Stem Cell 16:477-487, 2015; Curr Med Chem 13:1877-1893, 2006)采集循环单核细胞进行转录组分析。转录谱分析和途径分析显示,LV EDVi 降低的患者表现出 I 型干扰素(IFN)信号转导的诱导(I 型 IFN 途径:P 值<0.001;错误发现率<0.001)。随后,我们在大鼠心肌梗死模型中在心肌梗死后连续 3 天每天给予 15,000 单位的 IFN-α 皮下注射。使用超声心动图测量心功能,使用(免疫)组织化学分析测量梗死面积/心脏炎症。我们发现,IFN-α 的应用恶化了心室扩张,并在心肌梗死后 28 天增加了梗死面积。此外,IFN-α 改变了外周单核细胞亚群向促炎单核细胞亚群的分布,而在心肌中,替代巨噬细胞亚群的存在在心肌梗死后第 3 天增加。我们的研究结果表明,人类单核细胞中 I 型 IFN 信号的诱导与不良的 LV 重构一致。然而,在大鼠中,IFN-α 的给药恶化了梗死后的愈合。这些发现强调了 I 型 IFN 反应在心肌梗死后心脏愈合过程中的重要但也有矛盾的作用。